期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis 被引量:13
1
作者 Chang-XinGeng Zhao-ChongZeng Ji-YaoWang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第4期696-700,共5页
AIM: To investigate the in vitro anti-hepatocellular carcinoma (HCC) activity of docetaxel against SMMC-7721 HCC cells and its possible mechanism.METHODS: The HCC cells were given different concentrations of docetaxel... AIM: To investigate the in vitro anti-hepatocellular carcinoma (HCC) activity of docetaxel against SMMC-7721 HCC cells and its possible mechanism.METHODS: The HCC cells were given different concentrations of docetaxel and their growth was measured by colony forming assay. Cell cycle and apoptosis were analyzed by flow cytometry and fluorescence microscopy (acridine orange/ethidium bromide double staining, AO/EB), as well as electronic microscopy. The SMMC-7721 HCC cell reactive oxygen species (ROS) and glutathione (GSH) were measured after given docetaxel.RESULTS: Docetaxel inhibited the hepatocellular carcinoma cells growth in a concentration dependent manner with IC505×10-10 M. Marked cell apoptosis and G2/M phase arrest were observed after treatment with docetaxel ≥10-8M.Docetaxel promoted SMMC-7721 HCC cells ROS generation and GSH deletion.CONCLUSION: Docetaxel suppressed the growth of SMMC7721 HCC cells in vitro by causing apoptosis and G2/M phase arrest of the human hepatoma cells, and ROS and GSH may play a key role in the inhibition of growth and induction of apoptosis. 展开更多
关键词 多舍西 肝细胞癌 化疗 细胞凋亡 SMMC-7721细胞系
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部